Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?
mesenchymal-epithelial transition (MET)
non-small cell lung cancer (NSCLC)
oncogene
predictive biomarkers
targeted therapy
tyrosine kinase inhibitors (TKIs)
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
14 Jun 2023
14 Jun 2023
Historique:
received:
20
05
2023
revised:
11
06
2023
accepted:
12
06
2023
medline:
29
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
In recent years, we have seen the development and approval for clinical use of an increasing number of therapeutic agents against actionable oncogenic drivers in metastatic non-small cell lung cancer (NSCLC). Among them, selective inhibitors, including tyrosine kinase inhibitors (TKIs) and monoclonal antibodies targeting the mesenchymal-epithelial transition (MET) receptor, have been studied in patients with advanced NSCLC with
Identifiants
pubmed: 37373267
pii: ijms241210119
doi: 10.3390/ijms241210119
pmc: PMC10299133
pii:
doi:
Substances chimiques
Proto-Oncogene Proteins c-met
EC 2.7.10.1
Protein Kinase Inhibitors
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Cancer Biol Ther. 2019;20(9):1183-1186
pubmed: 31131689
N Engl J Med. 2014 Nov 20;371(21):1963-71
pubmed: 25264305
Cancer Cell. 2010 Jan 19;17(1):77-88
pubmed: 20129249
Oncotarget. 2021 Aug 31;12(18):1802-1810
pubmed: 34504652
Target Oncol. 2023 Jan;18(1):105-118
pubmed: 36459255
J Thorac Oncol. 2020 Jan;15(1):80-90
pubmed: 31622732
Ann Transl Med. 2015 Apr;3(6):83
pubmed: 25992382
Mol Cancer. 2022 Jan 26;21(1):31
pubmed: 35081970
Clin Cancer Res. 2013 Jun 1;19(11):2941-51
pubmed: 23553846
Mol Cancer Ther. 2011 Dec;10(12):2298-308
pubmed: 21926191
Lung Cancer (Auckl). 2021 May 20;12:35-50
pubmed: 34295201
J Thorac Oncol. 2019 Apr;14(4):737-741
pubmed: 30639620
Ann Oncol. 2019 Aug 1;30(8):1321-1328
pubmed: 31125062
Lung Cancer. 2020 Dec;150:21-25
pubmed: 33045465
Front Mol Biosci. 2018 Oct 24;5:86
pubmed: 30406111
Invest New Drugs. 2013 Aug;31(4):833-44
pubmed: 23275061
JTO Clin Res Rep. 2022 Jul 22;3(9):100381
pubmed: 36082279
Diagn Pathol. 2015 Jul 28;10:130
pubmed: 26215852
J Clin Oncol. 2016 Mar 10;34(8):794-802
pubmed: 26215952
J Thorac Oncol. 2015 May;10(5):e29-e31
pubmed: 25898962
J Thorac Oncol. 2020 May;15(5):741-751
pubmed: 32169477
J Biomed Sci. 2020 Jan 2;27(1):1
pubmed: 31894001
Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(6):588-610
pubmed: 20551596
Curr Signal Transduct Ther. 2011;6(2):146-151
pubmed: 25197268
JCO Precis Oncol. 2023 Feb;7:e2200482
pubmed: 36848606
J Clin Oncol. 2017 Feb;35(4):412-420
pubmed: 27937096
Transl Lung Cancer Res. 2021 Jun;10(6):2667-2682
pubmed: 34295669
J Thorac Oncol. 2020 Apr;15(4):628-636
pubmed: 31945494
Lancet Respir Med. 2020 Nov;8(11):1132-1143
pubmed: 32479794
Ther Adv Med Oncol. 2011 Nov;3(1 Suppl):S7-S19
pubmed: 22128289
Mol Med. 2018 Sep 24;24(1):50
pubmed: 30249178
J Thorac Oncol. 2016 Aug;11(8):1293-1304
pubmed: 27262212
Biochim Biophys Acta. 2013 Jan;1833(1):122-39
pubmed: 23085373
Drugs. 2021 Sep;81(14):1665-1670
pubmed: 34455538
Nat Rev Cancer. 2018 Jun;18(6):341-358
pubmed: 29674709
Cancer Discov. 2020 Jul;10(7):922-934
pubmed: 32532746
Lancet Oncol. 2016 Dec;17(12):1661-1671
pubmed: 27825638
Front Oncol. 2022 Sep 23;12:1017026
pubmed: 36212500
Invest New Drugs. 2016 Jun;34(3):397-8
pubmed: 26892698
Nat Rev Cancer. 2012 Jan 24;12(2):89-103
pubmed: 22270953
Int J Mol Sci. 2022 Nov 11;23(22):
pubmed: 36430388
Front Oncol. 2022 Oct 21;12:1004198
pubmed: 36338701
Lung Cancer. 2022 Jan;163:59-68
pubmed: 34923203
ESMO Open. 2021 Dec;6(6):100319
pubmed: 34837746
N Engl J Med. 2020 Sep 3;383(10):931-943
pubmed: 32469185
N Engl J Med. 2020 Sep 3;383(10):944-957
pubmed: 32877583
Ann Oncol. 2018 Oct 1;29(10):2085-2091
pubmed: 30165371
J Clin Oncol. 2021 Oct 20;39(30):3391-3402
pubmed: 34339292
JTO Clin Res Rep. 2022 Sep 09;3(10):100407
pubmed: 36217329
J Clin Invest. 2022 Apr 15;132(8):
pubmed: 35426374
Nat Cancer. 2021 Apr;2(4):377-391
pubmed: 35122001
Clin Cancer Res. 2019 Feb 15;25(4):1248-1260
pubmed: 30352902
J Thorac Oncol. 2023 Apr;18(4):419-435
pubmed: 36441095
J Clin Oncol. 2022 Oct 1;40(28):3310-3322
pubmed: 35816666
Clin Cancer Res. 2013 Oct 15;19(20):5699-710
pubmed: 23989980
J Cancer. 2018 Apr 23;9(10):1836-1845
pubmed: 29805710
Lancet Respir Med. 2021 Oct;9(10):1154-1164
pubmed: 34166627
Nat Rev Clin Oncol. 2020 Sep;17(9):569-587
pubmed: 32514147
Lung Cancer. 2021 Nov;161:55-59
pubmed: 34536732
Nat Rev Mol Cell Biol. 2010 Dec;11(12):834-48
pubmed: 21102609
Cancers (Basel). 2022 May 14;14(10):
pubmed: 35626038
J Thorac Oncol. 2021 May;16(5):850-859
pubmed: 33545388
N Engl J Med. 2023 May 11;388(19):1767-1778
pubmed: 37163623
Transl Lung Cancer Res. 2021 Mar;10(3):1536-1556
pubmed: 33889528
Cancers (Basel). 2023 Jan 18;15(3):
pubmed: 36765572
Transl Lung Cancer Res. 2023 Feb 28;12(2):346-368
pubmed: 36895930
PLoS One. 2019 Oct 15;14(10):e0223926
pubmed: 31613934
Clin Cancer Res. 2019 May 15;25(10):3164-3175
pubmed: 30674502
Ann Oncol. 2018 Dec 1;29(12):2392-2393
pubmed: 30339198
Ann Oncol. 2023 Apr;34(4):339-357
pubmed: 36872130
JCO Precis Oncol. 2021 Aug 25;5:
pubmed: 34476332
Lung Cancer. 2023 Apr;178:254-268
pubmed: 36924573
Lung Cancer. 2023 Apr;178:66-74
pubmed: 36806896
Front Pharmacol. 2022 Mar 17;13:808855
pubmed: 35370682
Clin Lung Cancer. 2022 May;23(3):195-207
pubmed: 35272955
Clin Cancer Res. 2019 Dec 15;25(24):7312-7319
pubmed: 31416808
Ther Adv Med Oncol. 2022 Dec 26;14:17588359221144108
pubmed: 36601633
Oncotarget. 2017 Aug 4;8(40):68221-68229
pubmed: 28978110
Mol Oncol. 2014 Mar;8(2):378-88
pubmed: 24389243
Lung Cancer. 2017 Jan;103:27-37
pubmed: 28024693
Lung Cancer. 2015 Dec;90(3):369-74
pubmed: 26791794
Oncologist. 2019 Sep;24(9):e930-e942
pubmed: 30833489
Biochem Soc Trans. 2021 Apr 30;49(2):645-661
pubmed: 33860789
J Clin Pathol. 2015 Jun;68(6):405-9
pubmed: 25987653
Eur J Pharm Sci. 2019 Aug 1;136:104938
pubmed: 31132401
JCO Precis Oncol. 2023 Feb;7:e2200674
pubmed: 36848608
Cancer Discov. 2021 Nov;11(11):2726-2737
pubmed: 34099454
Genes Chromosomes Cancer. 2022 May;61(5):244-260
pubmed: 34997651
J Thorac Oncol. 2021 Apr;16(4):572-582
pubmed: 33309988
J Thorac Oncol. 2016 Sep;11(9):1493-502
pubmed: 27343443
Invest New Drugs. 2021 Apr;39(2):477-487
pubmed: 33052556
Clin Cancer Res. 2017 Nov 1;23(21):6661-6672
pubmed: 28765324
Cancer Res. 2014 Feb 1;74(3):884-95
pubmed: 24305878
N Engl J Med. 2013 Jun 20;368(25):2385-94
pubmed: 23724913
Ann Oncol. 2019 Dec 1;30(12):1985-1991
pubmed: 31584608
J Thorac Oncol. 2021 Jun;16(6):1017-1029
pubmed: 33676017
J Clin Oncol. 2022 Oct 1;40(28):3323-3343
pubmed: 35816668
Clin Lung Cancer. 2015 Sep;16(5):e101-4
pubmed: 25769807
J Thorac Oncol. 2015 May;10(5):e33-e34
pubmed: 25898965
Cancer Discov. 2015 Aug;5(8):850-9
pubmed: 25971938
Science. 2007 May 18;316(5827):1039-43
pubmed: 17463250
Nat Med. 2020 Jan;26(1):47-51
pubmed: 31932802
Clin Cancer Res. 2011 Nov 15;17(22):7127-38
pubmed: 21918175
Lung Cancer. 2021 Apr;154:142-145
pubmed: 33667719
Cancer Discov. 2015 Aug;5(8):842-9
pubmed: 25971939
JCO Precis Oncol. 2017;2017(1):
pubmed: 29527595
J Thorac Oncol. 2019 Oct;14(10):1753-1765
pubmed: 31279006
Trends Cancer. 2016 Jul;2(7):350-364
pubmed: 27819059
Lung Cancer. 2022 Jan;163:96-106
pubmed: 34942494
Oncotarget. 2018 Feb 08;9(17):13682-13693
pubmed: 29568386
Clin Cancer Res. 2020 Mar 15;26(6):1237-1246
pubmed: 31822497
J Thorac Oncol. 2019 Nov;14(11):2003-2008
pubmed: 31382039
Respir Res. 2023 Jan 25;24(1):28
pubmed: 36698189
J Clin Oncol. 2015 Aug 20;33(24):2667-74
pubmed: 26169611